Is Hypertension Treated Adequately? L. HanssonJ. I. S. Robertson Introductory Lecture 18 October 2012 Pages: 1 - 6
Pharmacodynamic Properties of Felodipine Bengt LjungM. Nordlander Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 7 - 15
Clinical Pharmacokinetics of Felodipine Boo EdgarP. LundborgC. G. Regårdh Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 16 - 27
Pharmacokinetics and Haemodynamics of Felodipine as Monotherapy in Hypertensive Patients Boo EdgarP. CollsteC. G. Regårdh Short Communication 18 October 2012 Pages: 28 - 29
Pharmacokinetics and Haemodynamics of Felodipine in Hypertensive Patients Treated Concomitantly with a β-Blocker Dag ElmfeldtB. BengtssonO. Rönn Short Communication 18 October 2012 Pages: 30 - 30
Effects of Impaired Renal Function on the Pharmacokinetics of Felodipine Boo EdgarM. AurellC. Shansky Short Communication 18 October 2012 Pages: 31 - 32
Pharmacokinetics of Felodipine and Effect on Digoxin Plasma Levels in Patients with Heart Failure Nina RehnqvistE. BillingG. Olsson Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 33 - 42
Metabolism of [14C] Felodipine, a New Vasodilating Drug, in Healthy Volunteers K. -J. HoffmannL. Andersson Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 43 - 52
Baroreflex Control of Renin Release in Spontaneously Hypertensive Rats after Administration of Felodipine Margareta NordlanderR. HortonP. Thalén Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 53 - 56
Poster Discussion: Section 1 G. DiBona Section 1: Pharmacology and Human Pharmacokinetics of Felodipine 18 October 2012 Pages: 57 - 58
Renal Effects of Felodipine in Hypertension G. LeonettiL. TerzoliAlberto Zanchetti Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 59 - 66
Effect of Long Term Felodipine Treatment on Renal Vascular Tone, Glomerular Filtration Rate and Renal Tubular Function in Essential Hypertension U. Lennart HulthénP. L. KatzmanB. Hökfelt Short Communication 18 October 2012 Pages: 67 - 68
Haemodynamic Effects of Felodipine during Supine Resting and Exercising States and Orthostatic Tilt in Patients with Chronic Congestive Heart Failure E. KassisS. WaldorffO. Amtorp Short Communication 18 October 2012 Pages: 69 - 70
Felodipine in Ischaemic Heart Disease J. V. SheridanP. ThomasD. J. Sheridan Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 71 - 78
Felodipine in Heart Failure Peter H. J. M. DunselmanC. E. E. KuntzeK. I. Lie Short Communication 18 October 2012 Pages: 79 - 80
Haemodynamic Effects of Felodipine in Congestive Heart Failure P. HeldK. Swedberg Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 81 - 84
The Effects of Felodipine on Left Ventricular Function in β-Blocked Patients A. J. Drake-HollandS. PughM. I. M. Noble Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 85 - 86
Hormonal and Blood Pressure Responses to Tilting in β-Blocked Essential Hypertension Treated with Felodipine or Prazosin B. JacksonB. P. McGrathC. I. Johnston Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 87 - 92
Glucose Tolerance and Secretion and Clearance of Insulin during Long Term Felodipine Treatment P. L. KatzmanU. Lennart HulthénB. Hökfelt Short Communication 18 October 2012 Pages: 93 - 94
Poster Discussion: Section 2 G. DiBona Section 2: Renal and Cardiac Effects of Felodipine 18 October 2012 Pages: 95 - 96
Felodipine in Hypertensive Patients H. E. Sluiter Section 3: Felodipine in Hypertension 18 October 2012 Pages: 97 - 106
Felodipine Monotherapy in Hypertension W. A. LittlerS. A. SmithP. J. E. Mace Short Communication 18 October 2012 Pages: 107 - 108
Felodipine versus Prazosin as an Addition to a β-Blocker in the Treatment of Essential Hypertension B. JacksonT. O. MorganA. Anderson Section 3: Felodipine in Hypertension 18 October 2012 Pages: 109 - 119
The Use of Felodipine in the Treatment of Severe Hypertension A. L. MuirC. G. Wathen Section 3: Felodipine in Hypertension 18 October 2012 Pages: 120 - 124
Comparison of Antihypertensive Effect and Pharmacokinetics of Conventional and Extended Release Felodipine Tablets in Patients with Arterial Hypertension T. HednerD. ElmfeldtE. Sjögren Section 3: Felodipine in Hypertension 18 October 2012 Pages: 125 - 131
Aspects on the Benefit-Risk Balance of Felodipine in Hypertension Dag ElmfeldtS. Westerling Section 3: Felodipine in Hypertension 18 October 2012 Pages: 132 - 135
Felodipine versus Hydrochlorothiazide as an Addition to a β-Blocker in the Treatment of Hypertension Harry BorgmästarsB. ForsénH. Ibsen Short Communication 18 October 2012 Pages: 136 - 138
Felodipine, a New Calcium Antagonist, as Monotherapy in Mild or Moderate Hypertension Cooperative Study GroupD. V. Hamilton Section 3: Felodipine in Hypertension 18 October 2012 Pages: 139 - 148
Hypertension in the Elderly R. Harvard DavisR. H. BurtonD. E. Ward Short Communication 18 October 2012 Pages: 149 - 150
Clinical Evaluation of Felodipine in Patients with Refractory Hypertension H. HerlitzS. BjörckM. Aurell Section 3: Felodipine in Hypertension 18 October 2012 Pages: 151 - 155
Felodipine in Combination with a β-Blocker and a Diuretic in Chronic Treatment of Patients with Refractory Primary Hypertension Ove K. AnderssonT. HednerG. Granérus Section 3: Felodipine in Hypertension 18 October 2012 Pages: 156 - 160
Clinical Evaluation of Felodipine in Hypertensive Patients Previously Treated with a Triple Drug Regimen Thomas Hedner Short Communication 18 October 2012 Pages: 161 - 161
Felodipine versus Moduretic® B. KrönigG. Flygt Section 3: Felodipine in Hypertension 18 October 2012 Pages: 162 - 169
Effects of Felodipine and Metoprolol on Blood Pressure, Plasma Renin, Angiotensin II, Aldosterone and Catecholamines in Hypertensive Patients P. LijnenR. FagardA. Amery Section 3: Felodipine in Hypertension 18 October 2012 Pages: 170 - 175
A Dose-Response Study of Felodipine in Patients Remaining Hypertensive on a β-Blocker Canadian Felodipine Study GroupA. G. Logan Short Communication 18 October 2012 Pages: 176 - 177
Short and Long Term Treatment of Essential Hypertension with Felodipine as Monotherapy K. HarringtonP. FitzgeraldK. O’Malley Section 3: Felodipine in Hypertension 18 October 2012 Pages: 178 - 185
Antihypertensive and Biochemical Effects of the Dihydropyridine Felodipine in the Long Term Treatment of Moderate to Severe Hypertension H. E. SluiterF. Th. M. HuysmansR. A. P. Koene Section 3: Felodipine in Hypertension 18 October 2012 Pages: 186 - 193
Felodipine Monotherapy in Systolic Hypertension in the Elderly L. M. H. WingJ. P. ChalmersA. E. Russell Section 3: Felodipine in Hypertension 18 October 2012 Pages: 194 - 197
Poster Discussion: Section 3 A. R. Lorimer Section 3: Felodipine in Hypertension 18 October 2012 Pages: 198 - 202
Panel Discussion A. ZanchettiG. DiBonaJ. I. S. Robertson Section 3: Felodipine in Hypertension 18 October 2012 Pages: 203 - 209